More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$92.43B
EPS
29.82
P/E ratio
18.9
Price to sales
1.58
Dividend yield
0.731%
Beta
1.104287
Previous close
$421.21
Today's open
$423.79
Day's range
$420.79 - $429.42
52 week range
$353.99 - $556.52
show more
CEO
Samuel N. Hazen
Employees
320000
Headquarters
Nashville, TN
Exchange
New York Stock Exchange
Shares outstanding
216501500
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA).
PRNewsWire • Sep 10, 2026

HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha • Sep 9, 2026

‘Big Short' Michael Burry just updated his portfolio for September
Michael Burry, a hedge fund manager and investor known for predicting the 2008 financial crash, has just updated his portfolio, with some notable new positions catching the market's attention.
Finbold • Sep 9, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
GlobeNewsWire • Sep 8, 2026

Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
Zacks Investment Research • Aug 28, 2026

HCA Healthcare, Inc. to Present at September Conferences
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and tim.
Business Wire • Aug 20, 2026

HCA workers push for higher pay and more staffing amid billions in profits: ‘I'm struggling'
Largest for-profit hospital system and operator in the US reported $6.8bn in profits, while employees find it difficult to make ends meet
The Guardian • Aug 11, 2026

Top 50 High-Quality Dividend Growth Stocks For August 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. The universe delivered a 10.44% YTD return through July, closely matching SPY but trailing SCHD, with several individual stocks significantly outperforming. Currently, 40 stocks in the universe offer a forward return estimate of at least 10%, with 25 appearing potentially undervalued based on free cash flow analysis.
Seeking Alpha • Aug 9, 2026

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare's East Florida Division, has been appointed president of HCA Healthcare's new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a.
Business Wire • Aug 6, 2026

HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm
If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
GlobeNewsWire • Aug 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell HCA Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.